6 March 2016 - The melanoma drug Keytruda should be funded here, Labour says -- despite the head of PHARMAC saying cancer experts here found no proof the drug helps people live longer.

For more details, go to: http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11601082